MainContent

John C. Lincoln Partnership with Phoenix CyberKnife and Radiation Oncology Center

Offers cancer patients the most advanced treatment options for solid-mass tumors

John C. Lincoln's medical staff members now have another advanced treatment option for their patients diagnosed with cancer.

Through a contractual agreement with Phoenix Cyberknife and Radiation Oncology Center, John C. Lincoln will play a role in providing stereotactic radiosurgery services for its cancer patients treated at the CyberKnife center.

Cyberknife's innovative stereotactic — or three dimensional – radiosurgery system offers greater precision, more effective radiation dosages and defined efficiency, the most advanced technology and treatment procedures currently available for cancer patients.

Since 1988, more than 100,000 patients have been treated with the CyberKnife system, which is now capable of delivering both intracranial and extra-cranial tumor treatments.

Advanced technology has expanded the CyberKnife's cancer fighting capabilities. Originally limited to treatment of brain tumors inside a patient's immobilized skull, CyberKnife now can continuously detect and tract the exact location of tumors in motion. This allows it to become the primary therapy for solid mass tumors throughout the body.

CyberKnife's radiosurgery technology:

  • Delivers high doses of radiation that ablate tumor cells.
  • Offers pinpoint precision with sub-millimeter accuracy for tumors in motion or fixed.
  • Spares surrounding healthy tissue from radiation exposure.
  • Treats tumors throughout the body – brain and spine, head and neck, lung, abdomen and pelvis.

To refer your patients to Phoenix CyberKnife and Radiation Oncology Center, 4611 E. Shea Blvd., Suite 120, Phoenix, AZ 85028, call 602-441-3845. For more information, visit them on line at phoenixcyberknife.com.

Return to main News page.